NEURALSTEM
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.
NEURALSTEM
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
1996-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.neuralstem.com
Total Employee:
11+
Status:
Active
Contact:
+30136649606
Total Funding:
39.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache ReCAPTCHA ReCAPTCHA V2 AdBlock Acceptable Ads Amazon Ireland Region Symantec Secure Site ASP.NET 2.0 Confluence Networks
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Stock Details
Investors List
Tianjin Pharmaceutical Group International Holdings
Tianjin Pharmaceutical Group International Holdings investment in Post-IPO Equity - NeuralStem
Hercules Capital
Hercules Capital investment in Post-IPO Debt - NeuralStem
Official Site Inspections
http://www.neuralstem.com
- Host name: 172.67.144.202
- IP address: 172.67.144.202
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
